Paul K Wotton

CIK 1300997 · President and CEO · last filed 2026-05-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$37.78M

Companies

5

Total Filings

58

Lifetime Open-Market Net

-$4.31M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VCEL Director 18,802 $37.46 $704.3K -$2.63M 21 2026-05-13
Ocata Therapeutics, Inc. (OCAT) Delisted President and CEO 0 $0 3 2016-02-11
ANTARES PHARMA, INC. (ATRS) Delisted President and CEO 670,734 $5.59 $3.75M -$1.72M 14 2014-02-24
AIS President and CEO 482,620 $76.82 $37.07M $35.1K 17 2012-05-21
GENAERA CORP (GENR) Delisted Director $0 2 2008-08-15

Recent Filings · Page 5 of 6

58 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-02-13 AIS Grant (A) +6,948 $0 EDGAR
2011-09-13 AIS Grant (A) +45,162 $0 EDGAR
2011-05-19 AIS Grant (A) +68,000 $0 EDGAR
2011-04-11 AIS Grant (A) +17,370 $0 EDGAR
2011-03-01 AIS Grant (A) +52,550 $0 EDGAR
2010-11-15 AIS Grant (A) $0 EDGAR
2010-08-24 AIS Buy (P) +10,000 $15.0K EDGAR
2010-02-24 AIS Grant (A) +53,846 $0 EDGAR
2009-11-13 AIS Grant (A) +25,000 $0 EDGAR
2009-08-14 AIS Grant (A) +50,000 $0 EDGAR
Showing 4150 of 58
Page 5 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.